SMAD3 and cancer: Zhang et al. (2025) demonstrated that in EGFR-TKI-resistant lung cancer, cancer-associated fibroblasts (CAFs) overexpressing collagen triple helix repeat-containing 1 (CTHRC1) activated TGF-β/Smad3 signaling to enhance glycolysis in cancer cells.